Ken Griffin Iridex Corp Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.97 - $3.53 $8,471 - $15,179
-4,300 Reduced 89.58%
500 $1,000
Q1 2024

May 15, 2024
SELL
$2.35 - $3.1 $3,760 - $4,960
-1,600 Reduced 25.0%
4,800 $14,000
Q4 2023

Feb 14, 2024
BUY
$1.9 - $3.28 $11,970 - $20,664
6,300 Added 6300.0%
6,400 $17,000
Q3 2023

Nov 14, 2023
BUY
$1.33 - $2.54 $133 - $254
100 New
100 $0
Q4 2022

Feb 14, 2023
BUY
$2.0 - $2.63 $2,800 - $3,682
1,400 New
1,400 $2,000

Others Institutions Holding IRIX

# of Institutions
31
Shares Held
3.25M
Call Options Held
500
Put Options Held
61.3K
View Full List

About IRIDEX CORP

IRIX Quotes by TradingView
  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $22.2M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email